Physician profile
Eric M Young
NPI 1033326335
$7,375.19
in general payments reported to CMS, 2019-2025
49 companies · $866 in 2025
The $866 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,496 · 2020: $1,995 · 2021: $761 · 2022: $663 · 2023: $544 · 2024: $1,050 · 2025: $866.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,459.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,378.69 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $588.48 | 2019-2025 | Belbuca, Xtampza |
| Abbvie INC. | $554.79 | 2021-2025 | Botox, Ubrelvy, Qulipta |
| Medtronic, INC. | $496.25 | 2021-2025 | Intellis Adaptivestim |
| Boston Scientific Corporation | $494.13 | 2020-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Bionic Navigator |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $468.81 | 2019-2024 | Relistor |
| Abbott Laboratories | $447.51 | 2019-2025 | Eterna, Proclaim, Ionicrf |
| Sirtex Medical INC | $228.97 | 2025 | Sir-Spheres Microspheres |
| Nevro Corp. | $207.55 | 2019-2023 | Senza |
| Teva Pharmaceuticals USA, INC. | $206.49 | 2019-2021 | |
| Allergan, INC. | $193.59 | 2019-2022 | |
| Daiichi Sankyo INC. | $183.16 | 2019 | |
| Vertiflex, INC. | $162.30 | 2019 | |
| Amgen INC. | $161.26 | 2019-2025 | Krystexxa |
| Arbor Pharmaceuticals, INC. | $128.56 | 2019-2021 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.